Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 104

1.

The cytoplasmic domain of tissue factor restricts physiological albuminuria and pathological proteinuria associated with glomerulonephritis in mice.

Apostolopoulos J, Moussa L, Tipping PG.

Nephron Exp Nephrol. 2010;116(4):e72-83. doi: 10.1159/000319320. Epub 2010 Jul 28.

PMID:
20664298
2.

Crescentic nephritis--is it in your genes?

Tipping PG.

Nephrol Dial Transplant. 2008 Oct;23(10):3065-6. doi: 10.1093/ndt/gfn402. Epub 2008 Jul 25. Review. No abstract available.

PMID:
18658179
3.

Are podocytes passive or provocative in proteinuric glomerular pathology?

Tipping PG.

J Am Soc Nephrol. 2008 Apr;19(4):651-3. doi: 10.1681/ASN.2008020156. Epub 2008 Mar 5. Review. No abstract available.

4.

The cytoplasmic domain of tissue factor in macrophages augments cutaneous delayed-type hypersensitivity.

Apostolopoulos J, Hickey MJ, Sharma L, Davenport P, Moussa L, James WG, Gregory JL, Kitching AR, Li M, Tipping PG.

J Leukoc Biol. 2008 Apr;83(4):902-11. doi: 10.1189/jlb.0607353. Epub 2008 Jan 7.

PMID:
18180372
5.

Leukocytes in glomerular injury.

Holdsworth SR, Tipping PG.

Semin Immunopathol. 2007 Nov;29(4):355-74. Epub 2007 Oct 16. Review.

PMID:
17938927
6.

Protease-activated receptor-2 augments experimental crescentic glomerulonephritis.

Moussa L, Apostolopoulos J, Davenport P, Tchongue J, Tipping PG.

Am J Pathol. 2007 Sep;171(3):800-8. Epub 2007 Jul 19.

7.

Cytokines in glomerulonephritis.

Tipping PG, Holdsworth SR.

Semin Nephrol. 2007 May;27(3):275-85. Review.

PMID:
17533006
8.

Toll-like receptors: the interface between innate and adaptive immunity.

Tipping PG.

J Am Soc Nephrol. 2006 Jul;17(7):1769-71. Epub 2006 Jun 14. No abstract available.

9.

T cells in crescentic glomerulonephritis.

Tipping PG, Holdsworth SR.

J Am Soc Nephrol. 2006 May;17(5):1253-63. Epub 2006 Apr 19.

10.

A pathogenetic role for mast cells in experimental crescentic glomerulonephritis.

Timoshanko JR, Kitching AR, Semple TJ, Tipping PG, Holdsworth SR.

J Am Soc Nephrol. 2006 Jan;17(1):150-9. Epub 2005 Nov 30.

11.

Conditional ablation of macrophages halts progression of crescentic glomerulonephritis.

Duffield JS, Tipping PG, Kipari T, Cailhier JF, Clay S, Lang R, Bonventre JV, Hughes J.

Am J Pathol. 2005 Nov;167(5):1207-19.

12.

Glomerulonephritis, Th1 and Th2: what's new?

Tipping PG, Kitching AR.

Clin Exp Immunol. 2005 Nov;142(2):207-15. Review.

13.

Contributions of intrinsic renal cells to crescentic glomerulonephritis.

Tipping PG, Timoshanko J.

Nephron Exp Nephrol. 2005;101(4):e173-8. Epub 2005 Sep 8. Review.

14.

Resident kidney cells and their involvement in glomerulonephritis.

Timoshanko JR, Tipping PG.

Curr Drug Targets Inflamm Allergy. 2005 Jun;4(3):353-62. Review.

PMID:
16101545
15.

Granulocyte macrophage colony-stimulating factor expression by both renal parenchymal and immune cells mediates murine crescentic glomerulonephritis.

Timoshanko JR, Kitching AR, Semple TJ, Holdsworth SR, Tipping PG.

J Am Soc Nephrol. 2005 Sep;16(9):2646-56. Epub 2005 Jul 20.

16.

CD80 and CD86 costimulatory molecules regulate crescentic glomerulonephritis by different mechanisms.

Odobasic D, Kitching AR, Tipping PG, Holdsworth SR.

Kidney Int. 2005 Aug;68(2):584-94.

17.

Glomerular expression of CD80 and CD86 is required for leukocyte accumulation and injury in crescentic glomerulonephritis.

Odobasic D, Kitching AR, Semple TJ, Timoshanko JR, Tipping PG, Holdsworth SR.

J Am Soc Nephrol. 2005 Jul;16(7):2012-22. Epub 2005 Jun 8.

18.

IL-12p40 and IL-18 in crescentic glomerulonephritis: IL-12p40 is the key Th1-defining cytokine chain, whereas IL-18 promotes local inflammation and leukocyte recruitment.

Kitching AR, Turner AL, Wilson GR, Semple T, Odobasic D, Timoshanko JR, O'Sullivan KM, Tipping PG, Takeda K, Akira S, Holdsworth SR.

J Am Soc Nephrol. 2005 Jul;16(7):2023-33. Epub 2005 May 11.

19.

Endogenous IL-13 limits humoral responses and injury in experimental glomerulonephritis but does not regulate Th1 cell-mediated crescentic glomerulonephritis.

Kitching AR, Turner AL, Wilson GR, Edgtton KL, Tipping PG, Holdsworth SR.

J Am Soc Nephrol. 2004 Sep;15(9):2373-82.

20.

Fibrin independent proinflammatory effects of tissue factor in experimental crescentic glomerulonephritis.

Cunningham MA, Kitching AR, Tipping PG, Holdsworth SR.

Kidney Int. 2004 Aug;66(2):647-54.

21.

The cytoplasmic domain of tissue factor contributes to leukocyte recruitment and death in endotoxemia.

Sharma L, Melis E, Hickey MJ, Clyne CD, Erlich J, Khachigian LM, Davenport P, Morand E, Carmeliet P, Tipping PG.

Am J Pathol. 2004 Jul;165(1):331-40.

22.

An IL-12-independent role for CD40-CD154 in mediating effector responses: studies in cell-mediated glomerulonephritis and dermal delayed-type hypersensitivity.

Ruth AJ, Kitching AR, Li M, Semple TJ, Timoshanko JR, Tipping PG, Holdsworth SR.

J Immunol. 2004 Jul 1;173(1):136-44.

24.

Contributions of IL-1beta and IL-1alpha to crescentic glomerulonephritis in mice.

Timoshanko JR, Kitching AR, Iwakura Y, Holdsworth SR, Tipping PG.

J Am Soc Nephrol. 2004 Apr;15(4):910-8.

25.

Intrinsic renal cell expression of CD40 directs Th1 effectors inducing experimental crescentic glomerulonephritis.

Ruth AJ, Kitching AR, Semple TJ, Tipping PG, Holdsworth SR.

J Am Soc Nephrol. 2003 Nov;14(11):2813-22.

26.
27.

Intrinsic renal cells are the major source of tumor necrosis factor contributing to renal injury in murine crescentic glomerulonephritis.

Timoshanko JR, Sedgwick JD, Holdsworth SR, Tipping PG.

J Am Soc Nephrol. 2003 Jul;14(7):1785-93.

28.

T cells in glomerulonephritis.

Tipping PG, Holdsworth SR.

Springer Semin Immunopathol. 2003 May;24(4):377-93. Review.

PMID:
12778334
29.

Plasminogen activator inhibitor-1 is a significant determinant of renal injury in experimental crescentic glomerulonephritis.

Kitching AR, Kong YZ, Huang XR, Davenport P, Edgtton KL, Carmeliet P, Holdsworth SR, Tipping PG.

J Am Soc Nephrol. 2003 Jun;14(6):1487-95.

30.

Effects of CTLA4-Fc on glomerular injury in humorally-mediated glomerulonephritis in BALB/c mice.

Kitching AR, Huang XR, Ruth AJ, Tipping PG, Holdsworth SR.

Clin Exp Immunol. 2002 Jun;128(3):429-35.

31.

Angiopoietin correlates with glomerular capillary loss in anti-glomerular basement membrane glomerulonephritis.

Yuan HT, Tipping PG, Li XZ, Long DA, Woolf AS.

Kidney Int. 2002 Jun;61(6):2078-89.

32.

Interleukin-10 inhibits experimental mesangial proliferative glomerulonephritis.

Kitching AR, Katerelos M, Mudge SJ, Tipping PG, Power DA, Holdsworth SR.

Clin Exp Immunol. 2002 Apr;128(1):36-43.

33.
34.

The requirement for granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in leukocyte-mediated immune glomerular injury.

Kitching AR, Ru Huang X, Turner AL, Tipping PG, Dunn AR, Holdsworth SR.

J Am Soc Nephrol. 2002 Feb;13(2):350-8.

35.

Crescentic glomerulonephritis is diminished in fibrinogen-deficient mice.

Drew AF, Tucker HL, Liu H, Witte DP, Degen JL, Tipping PG.

Am J Physiol Renal Physiol. 2001 Dec;281(6):F1157-63.

36.

Effects of combined oral hormone replacement therapy on tissue factor pathway inhibitor and factor VII.

Peverill RE, Teede HJ, Smolich JJ, Malan E, Kotsopoulos D, Tipping PG, McGrath BP.

Clin Sci (Lond). 2001 Jul;101(1):93-9.

PMID:
11410120
37.

Interleukin-12 from intrinsic cells is an effector of renal injury in crescentic glomerulonephritis.

Timoshanko JR, Kitching AR, Holdsworth SR, Tipping PG.

J Am Soc Nephrol. 2001 Mar;12(3):464-71.

38.

MHC class I pathway is not required for the development of crescentic glomerulonephritis in mice.

Li S, Holdsworth SR, Tipping PG.

Clin Exp Immunol. 2000 Dec;122(3):453-8.

39.

IL-18 has IL-12-independent effects in delayed-type hypersensitivity: studies in cell-mediated crescentic glomerulonephritis.

Kitching AR, Tipping PG, Kurimoto M, Holdsworth SR.

J Immunol. 2000 Oct 15;165(8):4649-57.

40.

Chemokines as therapeutic targets in renal disease.

Holdsworth SR, Kitching AR, Tipping PG.

Curr Opin Nephrol Hypertens. 2000 Sep;9(5):505-11. Review.

PMID:
10990369
41.

Crescentic glomerulonephritis--a manifestation of a nephritogenic Th1 response?

Kitching AR, Holdsworth SR, Tipping PG.

Histol Histopathol. 2000 Jul;15(3):993-1003. doi: 10.14670/HH-15.993. Review.

PMID:
10963141
42.

B7.1 and B7.2 co-stimulatory molecules regulate crescentic glomerulonephritis.

Li S, Holdsworth SR, Tipping PG.

Eur J Immunol. 2000 May;30(5):1394-401.

43.

Interleukin-10 inhibits macrophage-induced glomerular injury.

Huang XR, Kitching AR, Tipping PG, Holdsworth SR.

J Am Soc Nephrol. 2000 Feb;11(2):262-9.

44.

Protease-activated receptor 1 mediates thrombin-dependent, cell-mediated renal inflammation in crescentic glomerulonephritis.

Cunningham MA, Rondeau E, Chen X, Coughlin SR, Holdsworth SR, Tipping PG.

J Exp Med. 2000 Feb 7;191(3):455-62.

45.

Endogenous interleukin-10 regulates Th1 responses that induce crescentic glomerulonephritis.

Kitching AR, Tipping PG, Timoshanko JR, Holdsworth SR.

Kidney Int. 2000 Feb;57(2):518-25.

46.

Tissue factor and factor VIIa receptor/ligand interactions induce proinflammatory effects in macrophages.

Cunningham MA, Romas P, Hutchinson P, Holdsworth SR, Tipping PG.

Blood. 1999 Nov 15;94(10):3413-20.

47.

Immunopathogenesis of crescentic glomerulonephritis.

Tipping PG, Kitching AR, Cunningham MA, Holdsworth SR.

Curr Opin Nephrol Hypertens. 1999 May;8(3):281-6. Review.

PMID:
10456257
48.

Macrophage depletion by albumin microencapsulated clodronate: attenuation of cytokine release in macrophage-dependent glomerulonephritis.

D'Souza MJ, Oettinger CW, Shah A, Tipping PG, Huang XR, Milton GV.

Drug Dev Ind Pharm. 1999 May;25(5):591-6.

PMID:
10219527
49.

IFN-gamma mediates crescent formation and cell-mediated immune injury in murine glomerulonephritis.

Kitching AR, Holdsworth SR, Tipping PG.

J Am Soc Nephrol. 1999 Apr;10(4):752-9.

50.

Tissue factor pathway inhibitor expression in human crescentic glomerulonephritis.

Cunningham MA, Ono T, Hewitson TD, Tipping PG, Becker GJ, Holdsworth SR.

Kidney Int. 1999 Apr;55(4):1311-8.

Supplemental Content

Loading ...
Support Center